Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 278.89 Million | 178.06 Million | 104 Million | 98.88 Million | 96.2 Million | 26.59 Million |
| Cost of Revenue | 259.5 Million | 168.17 Million | 99.15 Million | 95.04 Million | 96.17 Million | 24.34 Million |
| Gross Profit | 19.38 Million | 9.89 Million | 4.85 Million | 3.84 Million | 31.02 Thousand | 2.25 Million |
| Operating Expenses | 4.55 Million | 2.97 Million | 4.22 Million | 2.85 Million | 3.36 Million | 2.44 Million |
| Selling, General and Administrative Expenses | 4.55 Million | 2.6 Million | 4.01 Million | 2.54 Million | 2.73 Million | 2.43 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -368 Thousand | -204 Thousand | -314.87 Thousand | -635.62 Thousand | -12.75 Thousand |
| Cost and Expenses | 264.06 Million | 171.14 Million | 103.37 Million | 97.89 Million | 99.54 Million | 26.79 Million |
| Operating Income | 14.83 Million | 6.92 Million | 629 Thousand | 983.9 Thousand | -3.33 Million | -198.55 Thousand |
| Interest Expense | - | 4.25 Million | 4.31 Million | 4.74 Million | 4.42 Million | 4.21 Million |
| Income Tax Expense | 1.47 Million | 1.18 Million | 4000.00 | 481.5 Thousand | 244.08 Thousand | -161.14 Thousand |
| Earnings before Tax | 6.95 Million | 7.16 Million | 3.33 Million | 1.23 Million | -2.05 Million | -4.4 Million |
| Net Income | 5.47 Million | 5.98 Million | 3.33 Million | 753.35 Thousand | -2.05 Million | -4.4 Million |
| Earnings Per Share Basic | 0.14 | 0.15 | 0.08 | 0.02 | -0.05 | -0.11 |
| Earnings Per Share Diluted | 0.14 | 0.15 | 0.08 | 0.02 | -0.05 | -0.11 |
| Weighted Average Shares Outstanding | 40 Million | 40 Million | 40 Million | 40 Million | 40 Million | 40 Million |
| Weighted Average Shares Outstanding (Diluted) | 40 Million | 40 Million | 40 Million | 40 Million | 40 Million | 40 Million |
| Gross Margin | 0.07 | 0.06 | 0.05 | 0.04 | 0.00 | 0.08 |
| EBIT Margin | 0.04 | 0.04 | 0.01 | 0.01 | -0.03 | -0.01 |
| Profit Margin | 0.02 | 0.03 | 0.03 | 0.01 | -0.02 | -0.17 |
| EBITDA | 11.2 Million | 11.37 Million | 8.56 Million | 2.88 Million | 2.36 Million | -198.55 Thousand |
| Earnings Before Tax Margin | 0.05 | 0.04 | 0.01 | 0.01 | -0.03 | -0.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 30 Million | 24.42 Million | 278.35 Million | 44.22 Million | 65.61 Million | 76.22 Million |
| Cost of Revenue | 28.55 Million | 18.23 Million | 264.13 Million | 44.68 Million | 61.47 Million | 72.53 Million |
| Gross Profit | 1.45 Million | 6.18 Million | 14.21 Million | -458 Thousand | 4.13 Million | 3.69 Million |
| Operating Expenses | 401 Thousand | 1.52 Million | 3.61 Million | 991 Thousand | 1.23 Million | 514 Thousand |
| Selling, General and Administrative Expenses | 401 Thousand | 1.52 Million | - | 991 Thousand | 1.23 Million | 514 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | -368 Thousand | - | - | - |
| Cost and Expenses | 28.95 Million | 19.76 Million | 267.75 Million | 45.67 Million | 62.71 Million | 73.04 Million |
| Operating Income | 1.05 Million | 4.66 Million | 10.6 Million | -1.44 Million | 2.9 Million | 3.17 Million |
| Interest Expense | 915 Thousand | 929 Thousand | - | - | 1.01 Million | 1.08 Million |
| Income Tax Expense | 19 Thousand | -1.07 Million | 1.47 Million | 1.47 Million | 1000.00 | -1000.00 |
| Earnings before Tax | 155 Thousand | 2.65 Million | 6.95 Million | -2.66 Million | 2.06 Million | 2.61 Million |
| Net Income | 155 Thousand | 2.65 Million | 5.47 Million | -4.13 Million | 2.06 Million | 2.61 Million |
| Earnings Per Share Basic | 0.00 | 0.07 | - | -0.10 | 0.05 | 0.07 |
| Earnings Per Share Diluted | 0.00 | 0.07 | - | -0.10 | 0.05 | 0.07 |
| Weighted Average Shares Outstanding | 40 Million | 37.97 Million | 40 Million | 40 Million | 40 Million | 40 Million |
| Weighted Average Shares Outstanding (Diluted) | 40 Million | 37.97 Million | 40 Million | 40 Million | 40 Million | 40 Million |
| Gross Margin | 0.05 | 0.25 | 0.05 | -0.01 | 0.06 | 0.05 |
| EBIT Margin | 0.04 | 0.15 | - | -0.03 | 0.04 | 0.04 |
| Profit Margin | 0.01 | 0.11 | 0.02 | -0.09 | 0.03 | 0.03 |
| EBITDA | 1.11 Million | 3.61 Million | - | -1.34 Million | 2.91 Million | 3.18 Million |
| Earnings Before Tax Margin | 0.04 | 0.19 | 0.04 | -0.03 | 0.04 | 0.04 |
1879
BDRAF
ORIBEVER
ELECF
AANANDALAK
SARMF